Quantcast
Saturday, November 23, 2024

Biden’s FDA Chief Claims Misinformation the Leading Cause of Death

'I still believe that we must act now to change the culture at the FDA... '

(Alex Tien, Headline USAIt’s easy to see why public trust in government-run health organizations are in complete free fall. This week, President Biden’s newly-appointed chief of the Food and Drug Administration stated that the leading cause of death in the United States is “misinformation.”

In a recent CNN interview, FDA boss Robert Califf said that “the issue that keeps me up at night… is the proliferation of false and misleading health information, particularly online — and the distrust in institutions, data, and expertise that it has wrought,” Legal Insurrection reported.

“I believe that misinformation is now our leading cause of death,” Califf said, discussing the resistance to COVID-19 vaccines, the number of people embracing the drug ivermectin, as well as an increase in the use of e-cigarettes.

Califf also lamented that the FDA is not trusted by the public as much anymore, stating that, “Historically, the FDA has been relatively quiet and puts out definitive information through guidance or labels or regulatory actions that would be transmitted to consumers and patients through trusted intermediaries.

“But the world has changed at this point,” Califf said.

Califf’s appointment was notably opposed by Sen. Joe Manchin, D-W.Va., who has been a rare maverick willing to vote against his own party in some cases.

Manchin remarked that he was disappointed in Califf’s nomination.

““The fight I led against Dr. Califf was not personal. It was a fight to change the culture of the FDA starting from the top,” Manchin stated.

“I still believe that we must act now to change the culture at the FDA if we have any hope of stopping the prescription drug abuse epidemic that is ravaging our nation.”

If the new FDA’s recent remarks are any sign of what’s to come, the early signs indicate that Manchin was completely justified in his concern of Biden’s appointment.

 

Copyright 2024. No part of this site may be reproduced in whole or in part in any manner other than RSS without the permission of the copyright owner. Distribution via RSS is subject to our RSS Terms of Service and is strictly enforced. To inquire about licensing our content, use the contact form at https://headlineusa.com/advertising.
- Advertisement -

TRENDING NOW

TRENDING NOW